EMA backs Wegovy cardiovascular label update as Novo seeks EU coverage
The EMA recommended a label update that allows the drug to be used to reduce cardiovascular risk.
Regulation
How a potential Harris presidency could influence US healthcare
UK NICE recommends Accord’s Relugolix for prostate cancer
EMA accepts GSK’s Blenrep MAA for multiple myeloma for review
FDA issues CRL to Orexo’s NDA for opioid overdose medication
New Labour government backs pharma reform in UK
FDA grants priority review for Neurocrine’s crinecerfont NDAs
EMA fast-tracks review of AstraZeneca’s sipavibart to stop Covid
